Azenta Signs Definitive Agreement to Sell B Medical Systems to Thelema for USD 63 Million
Azenta, Inc., a leading provider of life sciences solutions worldwide, announced that its affiliate, Azenta Germany GmbH, has signed a binding agreement for the sale of Azenta's B Medical Systems business to Thelema S.À R.L., for a purchase price of USD 63 million. The transaction is expected to close on or before March 31, 2026.
Azenta | 30/12/2025 | By Darshana
UK Biocentre Picks Azenta's BioArc Ultra Automated Storage System to Power Research Excellence
UK Biocentre will utilize the new BioArc Ultra™ to deliver on critical research projects including the United Kingdom’s largest health research program – Our Future Health.
Azenta | 31/01/2025 | By Aishwarya | 153
Azenta Receives Regulatory Approval for Clinical Long-Read WGS Test
Performed within GENEWIZ from Azenta Life Sciences' CLIA-certified and CAP-accredited state-of-the-art clinical genomics laboratory, the test enables precise detection of a range of complex genomic alterations that are features of many rare diseases and undetectable by traditional approaches.
Azenta | 15/11/2024 | By Aishwarya | 285
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy